EV/EBITDA
0.04
0.000.00%
Wed, 12 Mar 2025 20:00:00 GMT
Summary
- As of March 12, 2025, SONN EV/EBITDA is 0.04, unchanged from the previous trading day.
- Over the past year, SONN EV/EBITDA has increased by +0.23 (+121.05%).
- SONN EV/EBITDA is now -83.33% below its all-time high of 0.24.
Performance
SONN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SONN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | +5.9% | +0.7% |
| 1 m1 month | +300.0% | -223.1% | -7.3% |
| 3 m3 months | +109.5% | -109.9% | -24.8% |
| 6 m6 months | +166.7% | -164.6% | -78.3% |
| ytdytd | +33.3% | -26.9% | -4.2% |
| 1 y1 year | +121.0% | -118.2% | -90.3% |
| 5 y5 years | - | - | -100.0% |
SONN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.01 | +500.0% | |
| 3 m | 3-month | 0.04 | at high | -0.45 | +108.9% |
| 6 m | 6-month | 0.04 | at high | -0.45 | +108.9% |
| 1 y | 1-year | 0.06 | -33.3% | -0.45 | +108.9% |
| 3 y | 3-year | 0.24 | -83.3% | -0.63 | +106.3% |
| 5 y | 5-year | 0.24 | -83.3% | -759.03 | +100.0% |
| alltime | all time | 0.24 | -83.3% | -759.03 | +100.0% |
Sonnet BioTherapeutics Holdings EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.04(+33.3%) |
| 2024 | 0.03(-117.6%) |
| 2023 | -0.17(-37.0%) |
| Date | Value |
|---|---|
| 2022 | -0.27(+28.6%) |
| 2021 | -0.21(-89.0%) |
| 2020 | -1.91 |
FAQ
- What is Sonnet BioTherapeutics Holdings EV/EBITDA?
- What is the all time high EV/EBITDA for Sonnet BioTherapeutics Holdings?
- What is SONN EV/EBITDA year-to-date change?
- What is Sonnet BioTherapeutics Holdings EV/EBITDA year-on-year change?
What is Sonnet BioTherapeutics Holdings EV/EBITDA?
The current EV/EBITDA of SONN is 0.04
What is the all time high EV/EBITDA for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high EV/EBITDA is 0.24
What is SONN EV/EBITDA year-to-date change?
Sonnet BioTherapeutics Holdings EV/EBITDA has changed by +0.01 (+33.33%) since the beginning of the year
What is Sonnet BioTherapeutics Holdings EV/EBITDA year-on-year change?
Over the past year, SONN EV/EBITDA has changed by +0.23 (+121.05%)